STERO Biotechs is a biotechnology company engaged in the research and development of cannabidiol (CBD)-based treatment solutions. It develops ST-101, a product that is is targeted for steroid sparing in multiple indications. STERO's main focus is aimed at inflammatory bowel diseases (IBD) and steroid-dependent Crohn’s disease.